ATE346299T1 - Nachweis einer msrv-1 induzierten superantigenaktivität in einer biologischen probe - Google Patents

Nachweis einer msrv-1 induzierten superantigenaktivität in einer biologischen probe

Info

Publication number
ATE346299T1
ATE346299T1 AT00912720T AT00912720T ATE346299T1 AT E346299 T1 ATE346299 T1 AT E346299T1 AT 00912720 T AT00912720 T AT 00912720T AT 00912720 T AT00912720 T AT 00912720T AT E346299 T1 ATE346299 T1 AT E346299T1
Authority
AT
Austria
Prior art keywords
msrv
induced
detection
biological sample
superantigen activity
Prior art date
Application number
AT00912720T
Other languages
German (de)
English (en)
Inventor
Herve Perron
Monique Lafont
Original Assignee
Bio Merieux
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9903622A external-priority patent/FR2791139B1/fr
Application filed by Bio Merieux filed Critical Bio Merieux
Application granted granted Critical
Publication of ATE346299T1 publication Critical patent/ATE346299T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rehabilitation Therapy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT00912720T 1999-03-19 2000-03-20 Nachweis einer msrv-1 induzierten superantigenaktivität in einer biologischen probe ATE346299T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9903622A FR2791139B1 (fr) 1999-03-19 1999-03-19 Procede de detection d'une activite superantigenique dans un echantillon biologique
FR9913755A FR2791140B1 (fr) 1999-03-19 1999-10-28 Procede de detection d'une activite superantigenique dans un echantillon et composition therapeutique ou prophylactique

Publications (1)

Publication Number Publication Date
ATE346299T1 true ATE346299T1 (de) 2006-12-15

Family

ID=26234877

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00912720T ATE346299T1 (de) 1999-03-19 2000-03-20 Nachweis einer msrv-1 induzierten superantigenaktivität in einer biologischen probe

Country Status (10)

Country Link
US (1) US20060088820A1 (https=)
EP (1) EP1163522B1 (https=)
JP (1) JP2002539804A (https=)
AT (1) ATE346299T1 (https=)
AU (1) AU3437700A (https=)
CA (1) CA2366552A1 (https=)
DE (1) DE60031963T2 (https=)
ES (1) ES2276675T3 (https=)
FR (1) FR2791140B1 (https=)
WO (1) WO2000057185A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010148323A2 (en) * 2009-06-18 2010-12-23 Whittemore Peterson Institute For Neuro-Immune Disease Diagnosis and treatment of diseases or disorders associated with xenotropic murine leukemia virus
US20110151431A1 (en) * 2009-06-18 2011-06-23 Whittemore Peterson Institute For Neuro-Immune Disease Detection of xenotropic murine leukemia virus
US20110117056A1 (en) * 2009-06-18 2011-05-19 Whittemore Peterson Institute For Neuro-Immune Disease Diagnosis and treatment of diseases or disorders associated with xenotropic murine leukemia virus
US20100167268A1 (en) * 2009-07-15 2010-07-01 Mikovits Judy A Seroconversion assays for detecting xenotropic murine leukemia virus-related virus
EP2949342A1 (en) * 2014-05-28 2015-12-02 Geneuro SA Antiretroviral drug targeting human endogenous retrovirus
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9310657D0 (en) * 1993-05-24 1993-07-07 Univ London Retrovirus
WO1998026747A2 (en) * 1996-12-17 1998-06-25 Terman David S Superantigen based methods and compositions for treatment of diseases
FR2765588A1 (fr) * 1997-07-07 1999-01-08 Bio Merieux Materiel nucleique retroviral et fragments nucleotidiques notamment associes a la sclerose en plaques et/ou la polyarthrite rhumatoide, a des fins de diagnostic, prophylactiques et therapeutiques

Also Published As

Publication number Publication date
DE60031963D1 (de) 2007-01-04
JP2002539804A (ja) 2002-11-26
FR2791140A1 (fr) 2000-09-22
CA2366552A1 (fr) 2000-09-28
US20060088820A1 (en) 2006-04-27
WO2000057185A1 (fr) 2000-09-28
ES2276675T3 (es) 2007-07-01
EP1163522A1 (fr) 2001-12-19
FR2791140B1 (fr) 2002-03-22
AU3437700A (en) 2000-10-09
DE60031963T2 (de) 2007-06-14
EP1163522B1 (fr) 2006-11-22

Similar Documents

Publication Publication Date Title
DK1389241T3 (da) Polynucleotid-sekventeringsfremgangsmåde
GB9700012D0 (en) Improvements in the detection of bacteria
DE50109428D1 (de) Nachweisverfahren, in welchem der High-Dose-Hook-Effekt vermieden, verringert oder nachgewiesen wird
DK0645015T3 (da) Forbedringer ved eller i forbindelse med analytpåvisning.
FR2701117B1 (fr) Système de mesures électrochimiques à capteur multizones, et son application au dosage du glucose.
DE59708087D1 (de) Elektrochemischer sensor
ATE279531T1 (de) Test zum nachweis der aktivität von phospho-n- acetylmuramyl-pentapeptid-translokase
ATE321886T1 (de) Oligonukleotide und diese enthaltende komplexe zur detektion der anwesenheit oder abwesenheit einer zielnukleinsäure in einer probe
ATE318930T1 (de) Nukleinsäuresonden zur detektion von candida- spezies
ATE346299T1 (de) Nachweis einer msrv-1 induzierten superantigenaktivität in einer biologischen probe
DK1123042T3 (da) Föling af öretemperatur, akustisk refleksion og kemiske bestanddele i öret
ITTO990882A0 (it) Procedimento e dispositivo per la determinazione della concentrazione di eparina in un campione di fluido.
BR0317472A (pt) Sensor colorimétrico e método para detectar um analito, kit descartável para detectar a presença de um analito, método para detectar a presença de bactérias, e, artigo médico
BRPI0016249B1 (pt) utilização de um substrato cromogênico e composição que permite a detecção de pelo menos uma cepa e/ou uma espécie de microorganismos.
ATE323912T1 (de) Prüfung von fingerabdrücken
DE59808639D1 (de) Verfahren zur bestimmung von schilddrüsen-autoantikörpern
SE0102896D0 (sv) System and method for blood analysis
EP0975794A4 (en) METHOD FOR DETERMINING PROCARBOXYPETIDASE-A AND CARBOXYPEPTIDASE-A MIRRORS IN BIOLOGICAL LIQUIDS
BR9510669A (pt) Método para determinar ou detectar danos em órgão de doador em seguida ao xenotransplante com base em analitos derivados do órgão do doador
ATE242483T1 (de) Chemosensitivitätsbestimmung über phosphatidylserin
ATE274183T1 (de) Diffusionskontrollierende sensorschicht
IL143639A0 (en) Method for determining the activity of a substance using a functional test in vitro
ATE422553T1 (de) Nachweis von virusstabilität
ATE206167T1 (de) Verfahren und elektrochemisch-enzymatisches indikationssystem zur bestimmung von nitrit
ATE250140T1 (de) Chemosensitivitätsmessung über caspase-aktivität

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties